Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

Overview

The purpose of this pilot study is to investigate the use of minocycline and doxycycline as medical therapy for inoperable or partially treated arteriovenous malformations (AVMs) and giant aneurysms.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2008

Detailed Description

Arteriovenous malformations (AVMs) are a treatable cause of stroke in young adults. The processes by which AVMs and giant aneurysms grow in size and spontaneously bleed are unknown. The primary reason to treat AVMs and aneurysms is to guard against intracranial bleeding. This pilot study will examine the use of two common antibiotics-minocycline and doxycycline-as medical therapy for inoperable or partially treated AVMs and giant aneurysms. These drugs, which are tetracycline derivatives, can reduce the levels of a family of enzymes, called matrix metalloproteases, that degrade tissue and thereby cause a reduction in the risk of spontaneous bleeding from AVMs or aneurysm-which is the main cause of stroke associated with these disorders. The enzymes can contribute to weaknesses in the wall of blood vessels and may increase the risk of the vessel wall rupturing and causing spontaneous bleeding. This trial also will show that taking minocycline and doxycycline over an extended period in this patient population is safe and well tolerated. Results from this study could help plan future studies to benefit patients with abnormal blood vessels prone to bleeding in their brains.

Interventions

  • Drug: minocycline
    • Take minocycline 50mg BID x2 years. Labs drawn at baseline, then every-6 months. MRI is done at baseline and completion of study.
  • Drug: doxycycline
    • Take doxycycline 50mg BID x2 years. Labs drawn at baseline, then every-6 months. MRI is done at baseline and completion of study.

Arms, Groups and Cohorts

  • Active Comparator: Brain AVMs
    • This trial is to investigate the use of minocycline or doxycycline as medical therapy, can minocycline or doxycycline induce biologically significant changes in the enzyme system thought to be related to spontaneous growth/rupture of these malformations. Finally, can patients safely tolerate these medications over an extended period of time.
  • Active Comparator: Aneurysms

Clinical Trial Outcome Measures

Primary Measures

  • MRI will be done baseline and post treatment.
    • Time Frame: 2 years
  • MMP levels are being followed q 6-mos.
    • Time Frame: Patients called weekly for 1st-3 months, then every 6-months until completion of study
  • Drug levels are being followed q 6-mos.
    • Time Frame: Patients called weekly for 1st-3 months, then every 6-months until completion of study

Participating in This Clinical Trial

Inclusion Criteria

  • Giant aneurysms or brain arteriovenous malformations (BAVM) – Female patients of child bearing age using effective birth control, males – Creatinine no greater than 2.0 mg/dl – ALT no greater than 2 times upper limit of control Exclusion Criteria:

  • Unstable medical illness – Contraindications to Tetracycline – History of vestibular disease, (except benign positional vertigo) – Prior tetracycline use within 2 mos of baseline visit. – History of noncompliance with treatment or other protocols – History of systemic lupus – Patients not eligible for MRI

Gender Eligibility: All

Minimum Age: 13 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of California, San Francisco
  • Collaborator
    • National Institute of Neurological Disorders and Stroke (NINDS)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • William L. Young, MD, Principal Investigator, University of California, San Francisco

Citations Reporting on Results

Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis. 2008;25(1-2):157-63. doi: 10.1159/000113733. Epub 2008 Jan 23.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.